The Wall Street conference, i.e. the most important event in the Polish capital market, was held between 25 and 27 November 2020. This time it was organized on-line.
The conference is a meeting place for individual investors and capital market-related entities. Tens of lectures by best domestic experts, panel discussions and economic debates are held during the three days of the conference.
The event is organized by the Individual Investors Association (Stowarzyszenie Inwestorów Indywidualnych, SII) – the largest investor organization in Poland, which currently brings together over 16 thousand investors. More than 10 thousand of them decided to take part in the event, which translated into the large attendance figures.
The Bioceltix presentation, delivered by Paweł Wielgus – Member of the Company’s Management Board, gathered an audience of more than 100 participants. Several dozen questions were asked on the investor chat. The crowning point of the conference was our representative’s participation in the debate on building a state-of-the-art economy through effective cooperation between the public and the private sectors.
Puls Biznesu about our plans: Bioceltix announces that it will soon debut on NewConnect – the company has recently completed the pre-IPO round. So far, the company has obtained a total of approx. PLN 20 million in financing for the development of a still innovative method of treating pets ...
ArticleForbes about Polish start-ups in the coronavirus crisis: “The year 2020 was a big challenge for companies, individual sectors of the economy and probably all of us. In the coming weeks and months of 2021 it will be similar. The condition of start-ups is no exception here. it is easier and ...
ArticleAccording to the „Investors’ Zone”, an interesting year is being prepared on the stock exchange: “This year, an exceptionally large group of companies is choosing NewConnect. As many as 63 companies declared their willingness to enter the alternative market, and several more in the ...
ArticleGazeta Wrocławska wrote about us: “Bioceltix is working on innovative biological medicines used in the treatment of common autoimmune and inflammatory diseases in companion animals. The company from Wrocław has something to fight for. This is indicated by the numbers on the global drug ...
ArticleWe create at Bioceltix veterinary biological medicines, and in 2020 we announced plans for a stock exchange debut and we obtained a permit from the Main Pharmaceutical Inspector to manufacture veterinary biological drugs. Despite the pandemic, we continue our projects without downtime. You can ...
Article2019? It’s been a good year for Bioceltix. A victory in the Start-Up Challenge coupled with participation in accelerator programs as well as ...
Read fullMamstartup: Gallant has developed a non invasive method for retrieving stem cells which can be used to treat various ailments – from torn ...
Read fullBusiness Insider caught up with Łukasz Bzdzion, founder of the startup Bioceltix, who – together with his team – is developing ...
Read full
